Jan-Henning is an ERC grant-holder, Professor of Pediatrics & Pediatric Oncology, and director at the University of Halle (Saale).
Dirk is a Max Eder Fellow and Principal Investigator at Hannover Medical School. He specializes in CRISPR-Cas9 systems and modeling leukemia in mice.
Raj (postdoctoral fellow) works on patient-dervied xenograft models of pediatric AML and translational non-coding RNAs studies.
Daniela (postdoctoral fellow) works on mapping the interactomes of the GATA1 / GATA1s transcription factors.
Maurice (PhD student, HBRS Molecular Medicine) is using a lentiviral CRISPR-Cas9 system to model Down syndrome AML in vivo and in vitro.
Oriol (PhD student, independent) is investigating the interactive genetic network of the stem cell microRNA cluster miR-99a/105~125b.
Sofia (PhD student, HBRS Molecular Medicine) is studying the interplay between chromome 21 genes and GATA1s in Down syndrome AML.
Michelle (PhD student, HBRS Molecular Medicine) is using a CRISPR interference-based screening platform to investigate long non-coding RNAs in AML.
Dorit (PhD student, HBRS Molecular Medicine) is studying the deregulated network in Ezh2-mutated AML using state-of-the-art CRISPR-Cas9 technology.
Lonneke (PhD student, independent) is investigating interactions within the DLK1-DIO3 non-coding RNA locus in normal and malignant hematopoiesis.
Sabine (technician) models AML using lentiviral CRISPR-Cas9 systems in vitro.
Lucie (technician) supports the in vitro aspect of all non-coding RNA projects.